norfloxacin has been researched along with Remission, Spontaneous in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arav-Boger, R | 1 |
| Leibovici, L | 1 |
| Danon, YL | 1 |
1 trial available for norfloxacin and Remission, Spontaneous
| Article | Year |
|---|---|
Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs multiple-day treatment.
Topics: Adolescent; Adult; Bacteriuria; Colony Count, Microbial; Drug Administration Schedule; Female; Human | 1994 |